
Cyteir Therapeutics, Inc.
USD3.02
-0.07 (-2.27%)
CEO
Markus F. Renschler
IPO Date
2021-06-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.03
Prev. Close
$3.09
Day Low
$3.00
Day High
$3.09
52W Low
$1.65
52W High
$3.19
Market Cap
$0.11B
Volume
1.01M
| 3 Feb 2023 |
| Morgan Stanley |
| Equal Weight |
| Underweight |
| downgrade |
| 2 Feb 2023 | Morgan Stanley | Equal Weight | Underweight | downgrade |
| 30 Jan 2023 | B of A Securities | Buy | Neutral | downgrade |
| 29 Jan 2023 | B of A Securities | Buy | Neutral | downgrade |
| 20 Jan 2023 | JP Morgan | Overweight | Neutral | downgrade |
| 19 Jan 2023 | JP Morgan | Overweight | Neutral | downgrade |
| 9 Sept 2022 | Morgan Stanley | Overweight | Equal Weight | downgrade |